Rossing P - Search Results

1

Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.

Davies MJ, Bain SC, Atkin SL, Rossing P, Scott D, Shamkhalova MS, Bosch-Traberg H, Syrén A, Umpierrez GE. Davies MJ, et al. Among authors: rossing p. Diabetes Care. 2016 Feb;39(2):222-30. doi: 10.2337/dc14-2883. Epub 2015 Dec 17. Diabetes Care. 2016. PMID: 26681713 Clinical Trial.

2

Low birth weight. A risk factor for development of diabetic nephropathy?

Rossing P, Tarnow L, Nielsen FS, Hansen BV, Brenner BM, Parving HH. Rossing P, et al. Diabetes. 1995 Dec;44(12):1405-7. doi: 10.2337/diab.44.12.1405. Diabetes. 1995. PMID: 7589846

3

Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.

Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH. Tarnow L, et al. Among authors: rossing p. Diabetes. 1995 May;44(5):489-94. doi: 10.2337/diab.44.5.489. Diabetes. 1995. PMID: 7729604

4

Prevalence of arterial hypertension in diabetic patients before and after the JNC-V.

Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH. Tarnow L, et al. Among authors: rossing p. Diabetes Care. 1994 Nov;17(11):1247-51. doi: 10.2337/diacare.17.11.1247. Diabetes Care. 1994. PMID: 7821162

5

Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH. Nielsen FS, et al. Among authors: rossing p. Diabetes. 1994 Sep;43(9):1108-13. doi: 10.2337/diab.43.9.1108. Diabetes. 1994. PMID: 8070610 Clinical Trial.

6

Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.

Rossing P, Hommel E, Smidt UM, Parving HH. Rossing P, et al. Diabetes. 1993 May;42(5):715-9. doi: 10.2337/diab.42.5.715. Diabetes. 1993. PMID: 8482428

7

Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy.

Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirier O, Parving HH. Tarnow L, et al. Among authors: rossing p. Diabetes. 1996 Mar;45(3):367-369. doi: 10.2337/diab.45.3.367. Diabetes. 1996. PMID: 8593944

8

Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy.

Yokoyama H, Myrup B, Rossing P, Ostergaard PB. Yokoyama H, et al. Among authors: rossing p. Diabetes Care. 1996 May;19(5):441-5. doi: 10.2337/diacare.19.5.441. Diabetes Care. 1996. PMID: 8732706

9

Fish oil in diabetic nephropathy.

Rossing P, Hansen BV, Nielsen FS, Myrup B, Hølmer G, Parving HH. Rossing P, et al. Diabetes Care. 1996 Nov;19(11):1214-9. doi: 10.2337/diacare.19.11.1214. Diabetes Care. 1996. PMID: 8908382 Clinical Trial.

10

Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH. Tarnow L, et al. Among authors: rossing p. Diabetes Care. 1996 Dec;19(12):1382-7. doi: 10.2337/diacare.19.12.1382. Diabetes Care. 1996. PMID: 8941468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

782 results

Search Page

Filters